Skip to main content
PMC home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2002 Nov 15;41(12):1821–1829. doi: 10.1016/0006-2952(91)90120-T

Broad-spectrum antiviral and cytocidal activity of cyclopentenylcytosine, a carbocyclic nucleoside targeted at CTP synthetase

Erik de Clercq ∗,†, Junichi Murase ‡,§, Victor E Marquez ∂
PMCID: PMC7111160  PMID: 1710119

Abstract

Cyclopentenylcytosine (Ce-Cyd) is a broad-spectrum antiviral agent active against DNA viruses [herpes (cytomegalo), pox (vaccinia)], (+)RNA viruses [picorna (polio, Coxsackie, rhino), toga (Sindbis, Semliki forest), corona], (−)RNA viruses [orthomyxo (influenza), paramyxo (parainfluenza, measles), arena (Junin, Tacaribe), rhabdo (vesicular stomatitis)] and (±)RNA viruses (reo). Ce-Cyd is a more potent antiviral agent than its saturated counterpart, cyclopentylcytosine (carbodine, C-Cyd). Ce-Cyd also has potent cytocidal activity against a number of tumor cell lines. The putative target enzyme for both the antiviral and antitumor action of Ce-Cyd is assumed to be the CTP synthetase that converts UTP to CTP. In keeping with this hypothesis was the finding that the antiviral and cytocidal effects of Ce-Cyd are readily reversed by Cyd and, to a lesser extent, Urd, but not by other nucleosides such as dThd or dCyd. In contrast, pyrazofurin and 6-azauridine, two nucleoside analogues that are assumed to interfere with OMP decarboxylase, another enzyme involved in the biosynthesis of pyrimidine ribonucleotides, potentiate the cytocidal activity of Ce-Cyd. Ce-Cyd should be further pursued, as such and in combination with OMP decarboxylase inhibitors, for its therapeutic potential in the treatment of both viral and neoplastic diseases.

References

  • 1.Shealy YF, Frye JL, DuBois NF, Shaddix SC, Brockman RW. Carbocyclic analogues of 5-fluorouracil nucleosides. J Med Chem. 1981;24:1083–1086. doi: 10.1021/jm00141a013. [DOI] [PubMed] [Google Scholar]
  • 2.Shealy YF, O'Dell CA, Shannon WM, Arnett G. Carbocyclic analogues of 5-substituted uracil nucleosides: synthesis and antiviral activity. J Med Chem. 1983;26:156–161. doi: 10.1021/jm00356a008. [DOI] [PubMed] [Google Scholar]
  • 3.Herdewijn P, De Clercq E, Balzarini J, Vanderhaeghe H. Synthesis and antiviral activity of the carbocyclic analogues of (E)-5-(2-halovinyl)-2′-deoxyuridines and (E)-5-(2-halovinyl-2′-deoxycytidines. J Med Chem. 1985;28:550–555. doi: 10.1021/jm50001a003. [DOI] [PubMed] [Google Scholar]
  • 4.Shealy YF, O'Dell CA, Arnett G, Shannon WM. Synthesis and antiviral activity of the carbocyclic analogues of 5-ethyl-2′-deoxyuridine and of 5-ethynyl-2′-deoxyuridine. J Med Chem. 1986;29:79–84. doi: 10.1021/jm00151a013. [DOI] [PubMed] [Google Scholar]
  • 5.Shealy YF, O'Dell CA, Shannon WM, Arnett G. Carbocyclic analogues of 5′-amino-5′-deoxy- and 3′-amino-3′-deoxythymidines. J Med Chem. 1986;29:483–488. doi: 10.1021/jm00154a010. [DOI] [PubMed] [Google Scholar]
  • 6.Shealy YF, O'Dell CA, Arnett G, Shannon WM, Thorpe MC, Riordan JM, Coburn WC., Jr Carbocyclic analogues of 5-halocytosine nucleosides. J Med Chem. 1986;29:1720–1725. doi: 10.1021/jm00159a026. [DOI] [PubMed] [Google Scholar]
  • 7.Borthwick AD, Evans DN, Kirk BE, Biggadike K, Exall AM, Youds P, Roberts SM, Knight DJ, Coates JAV. Fluoro carbocyclic nucleosides: synthesis and antiviral activity of 2′- and 6′-fluoro carbocyclic pyrimidine nucleosides including carbocyclic 1-(2-deoxy-2-fluoro-β-d-arabinofuranosyl)-5-methyluracil and carbocyclic 1-(2-deoxy-2-fluoro-β-d-arabinofuranosyl)-5-iodouracil. J Med Chem. 1990;33:179–186. doi: 10.1021/jm00163a030. [DOI] [PubMed] [Google Scholar]
  • 8.Shealy YF, O'Dell CA. Carbocyclic analogs of cytosine nucleosides. J Heterocyclic Chem. 1980;17:353–358. [Google Scholar]
  • 9.Shannon WM, Arnett G, Westbrook L, Shealy YF, O'Dell CA, Brockman RW. Evaluation of carbodine, the carbocyclic analog of cytidine, and related carbocyclic analogs of pyrimidine nucleosides for antiviral activity against human influenza type A viruses. Antimicrob Agents Chemother. 1981;20:769–776. doi: 10.1128/aac.20.6.769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Lim M-I, Moyer JD, Cysyk RL, Marquez VE. Cyclopentenyluridine and cyclopentenylcytidine analogues as inhibitors of uridine-cytidine kinase. J Med Chem. 1984;27:1536–1538. doi: 10.1021/jm00378a002. [DOI] [PubMed] [Google Scholar]
  • 11.Marquez VE, Lim M-I, Treanor SP, Plowman J, Priest MA, Markovac A, Khan MS, Kaskar B, Driscoll JS. Cyclopentenylcytosine. A carbocyclic nucleoside with antitumor and antiviral properties. J Med Chem. 1988;31:1687–1694. doi: 10.1021/jm00117a004. [DOI] [PubMed] [Google Scholar]
  • 12.Glazer RI, Knode MC, Lim M-I, Marquez VE. Cyclopentenyl cytidine analogue. An inhibitor of cytidine triphosphate synthesis in human colon carcinoma cells. Biochem Pharmacol. 1985;34:2535–2539. doi: 10.1016/0006-2952(85)90539-8. [DOI] [PubMed] [Google Scholar]
  • 13.Moyer JD, Malinowski NM, Treanor SP, Marquez VE. Antitumor activity and biochemical effects of cyclopentenyl cytosine in mice. Cancer Res. 1986;46:3325–3329. [PubMed] [Google Scholar]
  • 14.Kang GJ, Cooney DA, Moyer JD, Kelley JA, Kim H-Y, Marquez VE, Johns DG. Cyclopentenylcytosine triphosphate. Formation and inhibition of CTP synthetase. J Biol Chem. 1989;264:713–718. [PubMed] [Google Scholar]
  • 15.De Clercq E, Bernaerts R, Shealy YF, Montgomery JA. Broad-spectrum antiviral activity of carbodine, the carbocyclic analogue of cytidine. Biochem Pharmacol. 1990;39:319–325. doi: 10.1016/0006-2952(90)90031-F. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ohnuma T, Roboz J, Shapiro ML, Holland JF. Pharmacological and biochemical effects of pyrazofurin in humans. Cancer Res. 1977;37:2043–2049. [PubMed] [Google Scholar]
  • 17.Cadman EC, Dix DE, Handschumacher RE. Clinical, biological, and biochemical effects of pyrazofurin. Cancer Res. 1978;38:682–688. [PubMed] [Google Scholar]
  • 18.Janeway CM, Cha S. Effects of 6-azauridine on nucleotides, orotic acid, and orotidine in L5178Y mouse lymphoma cells in vitro. Cancer Res. 1977;37:4382–4388. [PubMed] [Google Scholar]
  • 19.Sant ME, Lyons SD, Kemp AJ, McClure LK, Szabados E, Christopherson RI. Dual effects of pyrazofurin and 3-deazauridine upon pyrimidine and purine biosynthesis in mouse L1210 leukemia. Cancer Res. 1989;49:2645–2650. [PubMed] [Google Scholar]
  • 20.De Clercq E, Descamps J, Verhelst G, Walker RT, Jones AS, Torrence PF, Shugar D. Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus. J Infect Dis. 1980;141:563–574. doi: 10.1093/infdis/141.5.563. [DOI] [PubMed] [Google Scholar]
  • 21.De Clercq E, Beres J, Bentrude WG. Potent activity of 5-fluoro-2′-deoxyuridine and related compounds against thymidine kinase-deficient (TK−) herpes simplex virus: targeted at thymidylate synthase. Mol Pharmacol. 1987;32:286–292. [PubMed] [Google Scholar]
  • 22.Snoeck R, Sakuma T, De Clercq E, Rosenberg I, Holy A. (S)-1-(3-Hydroxy-2-phosphonylmethcxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication. Antimicrob Agents Chemother. 1988;32:1839–1844. doi: 10.1128/aac.32.12.1839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.De Clercq E, Luczak M. Fluoroimidazoles as antiviral agents and inhibitors of polynucleotide biosynthesis. Life Sci. 1975;17:187–194. doi: 10.1016/0024-3205(75)90502-0. [DOI] [PubMed] [Google Scholar]
  • 24.De Clercq E. Antiviral and antimetabolic activities of neplanocins. Antimicrob Agents Chemother. 1985;28:84–89. doi: 10.1128/aac.28.1.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Andrei G, De Clercq E. Inhibitory effect of selected antiviral compounds on arenavirus replication in vitro. Antiviral Res. 1990;14:287–300. doi: 10.1016/0166-3542(90)90009-v. [DOI] [PubMed] [Google Scholar]
  • 26.De Clercq E, Bernaerts R, Bergstrom DE, Robins MJ, Montgomery JA, Holy A. Antirhinovirus activity of purine nucleoside analogs. Antimicrob Agents Chemother. 1986;29:482–487. doi: 10.1128/aac.29.3.482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kawana F, Shigeta S, Hosoya M, Suzuki H, De Clercq E. Inhibitory effects of antiviral compounds on respiratory syncytial virus replication in vitro. Antimicrob Agents Chemother. 1987;31:1225–1230. doi: 10.1128/aac.31.8.1225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Hosoya M, Shigeta S, Nakamura K, De Clercq E. Inhibitory effect of selected antiviral compounds on measles (SSPE) virus replication in vitro. Antiviral Res. 1989;12:87–98. doi: 10.1016/0166-3542(89)90072-7. [DOI] [PubMed] [Google Scholar]
  • 29.Shigeta S, Konno K, Yokota T, Nakamura K, De Clercq E. Comparative activities of several nucleoside analogs against influenza A, B, and C viruses in vitro. Antimicrob Agents Chemother. 1988;32:906–911. doi: 10.1128/aac.32.6.906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.De Clercq E, Balzarini J, Torrence PF, Mertes MP, Schmidt CL, Shugar D, Barr PJ, Jones AS, Verhelst G, Walker RT. Thymidylate synthetase as target enzyme for the inhibitory activity of 5-substituted 2′-deoxyuridines on mouse leukemia L1210 cell growth. Mol Pharmacol. 1981;19:321–330. [PubMed] [Google Scholar]
  • 31.Sidwell RW, Huffman JH, Khare GP, Allen LB, Witkowski JT, Robins RK. Broad-spectrum antiviral activity of virazole: 1-β-d-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science. 1972;177:705–706. doi: 10.1126/science.177.4050.705. [DOI] [PubMed] [Google Scholar]
  • 32.De Clercq E, Cools M, Balzarini J. Homocysteine potentiates the antiviral and cytostatic activity of those nucleoside analogues that are targeted at S-adenosylhomocysteine hydrolase. Biochem Pharmacol. 1989;38:1771–1778. doi: 10.1016/0006-2952(89)90411-5. [DOI] [PubMed] [Google Scholar]
  • 33.De Clercq E. Biochemical aspects of the selective antiherpes activity of nucleoside analogues. Biochem Pharmacol. 1984;33:2159–2169. doi: 10.1016/0006-2952(84)90649-x. [DOI] [PubMed] [Google Scholar]
  • 34.De Clercq E, Sakuma T, Baba M, Pauwels R, Balzarini J, Rosenberg I, Holy A. Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrmidines. Antiviral Res. 1987;8:261–272. doi: 10.1016/s0166-3542(87)80004-9. [DOI] [PubMed] [Google Scholar]
  • 35.Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH. The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 1985;4:3021–3024. doi: 10.1002/j.1460-2075.1985.tb04038.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Reardon JE, Spector T. Herpes simplex virus type 1 DNA polymerase. J Biol Chem. 1989;264:7405–7411. [PubMed] [Google Scholar]
  • 37.St Clair MH, Richards CA, Spector T, Weinhold KJ, Miller WH, Langlois AJ, Furman PA. 3′-Azido-3′-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase. Antimicrob Agents Chemother. 1987;31:1972–1977. doi: 10.1128/aac.31.12.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.De Clercq E. S-Adenosylhomocysteine hydrolase inhibitors as broad-spectrum antiviral agents. Biochem Pharmacol. 1987;36:2567–2575. doi: 10.1016/0006-2952(87)90533-8. [DOI] [PubMed] [Google Scholar]
  • 39.De Clercq E, Cools M, Balzarini J, Marquez VE, Borcherding DR, Borchardt RT, Drach JC, Kitaoka S, Konno T. Broad-spectrum antiviral activities of neplanocin A, 3-deazaneplanocin A, and their 5′-nor derivatives. Antimicrob Agents Chemother. 1989;33:1291–1297. doi: 10.1128/aac.33.8.1291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Glazer RI, Cohen MB, Hartman KD, Knode MC, Lim M-I, Marquez VE. Induction of differentiation in the human promyelocytic leukemia cell line HL-60 by the cyclopentenyl analogue of cytidine. Biochem Pharmacol. 1986;35:1841–1848. doi: 10.1016/0006-2952(86)90301-1. [DOI] [PubMed] [Google Scholar]
  • 41.Grem JL, Allegra CJ. Enhancement of the toxicity and DNA incorporation of arabinosyl-5-azacytosine and 1-β-d-arabinofuranosylcytosine by cyclopentenyl cytosine. Cancer Res. 1990;50:7279–7284. [PubMed] [Google Scholar]
  • 42.Descamps J, De Clercq E. Broad-spectrum antiviral activity of pyrazofurin (pyrazomycin) In: Siegenthaler W, Lüthy R, editors. Current Chemotherapy. American Society for Microbiology; Washington, DC: 1978. pp. 354–357. [Google Scholar]
  • 43.Wyde PR, Gilbert BE, Ambrose MW. Comparison of the anti-respiratory syncytial virus activity and toxicity of papaverine hydrochloride and pyrazofurin in vitro and in vivo. Antiviral Res. 1989;11:15–26. doi: 10.1016/0166-3542(89)90017-x. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Pharmacology are provided here courtesy of Elsevier

RESOURCES